Long‐term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS

OBJECTIVE: Intraspinal human spinal cord‐derived neural stem cell (HSSC) transplantation is a potential therapy for amyotrophic lateral sclerosis (ALS); however, previous trials lack controls. This post hoc analysis compared ambulatory limb‐onset ALS participants in Phase 1 and 2 (Ph1/2) open‐label...

Descripción completa

Detalles Bibliográficos
Autores principales: Goutman, Stephen A., Brown, Morton B., Glass, Jonathan D., Boulis, Nicholas M., Johe, Karl, Hazel, Tom, Cudkowicz, Merit, Atassi, Nazem, Borges, Lawrence, Patil, Parag G., Sakowski, Stacey A., Feldman, Eva L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989736/
https://www.ncbi.nlm.nih.gov/pubmed/29928656
http://dx.doi.org/10.1002/acn3.567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989736/
https://www.ncbi.nlm.nih.gov/pubmed/29928656
http://dx.doi.org/10.1002/acn3.567

Ejemplares similares